# Genomics Data Quality Issues: Common Problems and Fixes

Most genomics data quality issues come down to a small set of recurring causes: decaying signal across sequencing cycles, adapter and barcode contamination, uneven coverage, batch effects, sample mix-ups, and metadata that does not match the data. The first thing to check is almost always the same. Run FastQC on the raw FASTQ files and look at two plots, per-base quality and adapter content. Those two plots reveal the majority of problems before you spend a single compute hour on alignment. If you already have alignment files, a tool such as Mapinsights can detect hidden non-random error patterns at the alignment level that read-level tools miss, because it clusters samples on quality control features and flags outliers tied to sequencing cycles, chemistry, and library preparation [1].

This article walks through each major problem in order of how often it appears, explains the mechanism behind it, gives you a concrete way to confirm it, and then lays out a diagnostic sequence and prevention practices you can adopt in your own bioinformatics [data management](/blog/guides/data-management-basics-principles-processes-and-best-practices) workflows.

## What Quality Means in Genomics Data

![Worked example showing that Q30 means a 1 in 1,000 chance of an incorrect base call and Q20 means a 1 in 100 error rate.](/article-images/illustrations/genomics-data-quality-issues-phred-error-rate.webp)

A few terms carry the weight of this article, so define them once up front.

**Phred quality score.** The probability that a base call is wrong, expressed on a log scale. Q30 means a 1 in 1,000 chance of an incorrect call and is the conventional floor for acceptable Illumina data. Q20 means a 1 in 100 error rate.

**Artifact.** A systematic, non-random error pattern introduced by the instrument, chemistry, or library preparation rather than by biology. Artifacts matter because they masquerade as signal. Mapinsights was built specifically to separate these hidden error patterns from true variants, and its [logistic regression](/blog/data-analysis/logistic-regression-definition-formula) model flags low-confidence variant sites using alignment-derived features [1].

**Batch effect.** Technical variation introduced by processing samples in different groups, such as different flow cells, reagent lots, operators, or run dates. Batch effects are the classic source of false associations in RNA-seq and other high-throughput assays [2].

**Coverage.** The average number of reads that overlap a given genomic position. Anomalies in [sequencing depth](/knowledge/diagnostics/molecular/how-to-calculate-sequencing-depth-and-coverage-for-your-ngs-run), whether global or localized, are one of the anomaly classes Mapinsights identifies in alignment data [1].

Quality is not one number. A dataset can pass a per-base quality filter and still fail because of contamination, swaps, or a batch confound that only shows up when you compare samples against each other. Proactive quality control exists because unanticipated biases and artifacts can drive false associations and compromise downstream analyses before anyone notices [2].

## Genomics Data Quality Issues, Ordered From Most Common to Rarest

### 1. Degrading per-base quality across cycles

![Comparison table of tail decay, whole-read quality failure and adapter read-through, with the confirming plot and the correct fix for each.](/article-images/illustrations/genomics-data-quality-issues-trim-or-rerun.webp)

**Mechanism.** As sequencing proceeds through each cycle, the population of clusters on the flow cell loses synchronization. Some strands fall a cycle ahead or behind, signal bleeds between neighboring clusters, and fluorescent reagents deplete. The result is a steady decline in base-call confidence as read position increases, which is why the right end of a 150-base read almost always scores worse than the left end. Quality problems tied specifically to sequencing cycles are one of the error classes documented in systematic QC surveys of alignment data [1].

**How to confirm.** Run FastQC and inspect the per-base sequence quality plot. A drop below Q30 near the tail is routine. A drop below Q20 across the whole read, or a sawtooth pattern, points to chemistry or instrument trouble. Mapinsights adds cycle-level error profiling on aligned data, which catches artifacts that only become visible after mapping [1].

**Fix.** Trim low-quality tails with cutadapt or Trimmomatic, then re-run FastQC to confirm the trim worked. If the entire read is poor, the run itself is suspect, and the correct fix is to contact the sequencing provider and request a rerun rather than trying to rescue bad data computationally. Heavy trimming is a patch, not a cure.

### 2. Adapter and barcode contamination

**Mechanism.** When the DNA fragment inserted into the library is shorter than the read length, the sequencer reads past the insert and into the adapter sequence. Adapter bases then misalign, inflate mismatch rates, and can be incorrectly incorporated into assemblies or variant calls. Overrepresented sequences in a FastQC report are frequently adapters.

**How to confirm.** In FastQC, check the "Adapter Content" and "Overrepresented sequences" modules. Running cutadapt in report-only mode against the expected adapter sequences gives you an exact contamination fraction.

```bash
fastqc *.fastq.gz
cutadapt -a AGATCGGAAGAGC -q 20 -m 50 \
  -o trimmed_R1.fastq.gz sample_R1.fastq.gz
multiqc .
```

**Fix.** Trim adapters explicitly with cutadapt or a similar tool before alignment. For the next batch, ask the library prep lab to size-select fragments so the insert is comfortably longer than the read length. Aggressive trimming of short inserts leaves little usable sequence, so the durable fix is at the library stage, not the analysis stage.

### 3. Uneven coverage, GC bias, and depth anomalies

**Mechanism.** PCR amplification during library preparation favors fragments with certain GC content, so some regions of the genome are systematically under- or overrepresented. Capture kits add their own target bias. The result is coverage that varies with local sequence composition rather than with biology, and localized depth anomalies that can mimic copy-number variation.

**How to confirm.** Plot per-base coverage across the genome with samtools or mosdepth and look for wave-like variation correlated with GC content. Mapinsights explicitly detects anomalies related to sequencing depth and flags outlier samples on alignment-derived features, which is useful when the problem is subtle enough to evade per-file inspection [1].

**Fix.** For whole-genome data, check that the depth anomaly follows GC content rather than gene boundaries, which distinguishes chemistry bias from a biological or structural signal. For targeted panels, restrict interpretation to on-target regions and use panels of normal samples. If one sample is a gross depth outlier relative to its group, suspect a loading concentration error and resequence it.

### 4. Contamination from index hopping, carryover, and cross-sample bleed

**Mechanism.** On patterned flow cells, index sequences can be misassigned between samples, a phenomenon known as index hopping. Carryover from a previous run's highly concentrated library and cross-contamination during plate handling produce similar symptoms. Downstream, contamination shows up as unexpected heterozygosity, low-level foreign alleles, and inflated variant counts.

**How to confirm.** Run FastQ Screen or Kraken2 on a subset of reads to test against expected and unexpected reference genomes. For human data, tools such as VerifyBamID estimate contamination from genotype concordance. A sex check (compare heterozygosity on the X chromosome against the reported sex) catches both swaps and cross-sample bleed.

**Fix.** Use unique dual indexes for multiplexed runs on patterned flow cells. Physically separate pre-PCR and post-PCR areas in the lab. If contamination is detected after sequencing, quantify it, and exclude or resequence affected samples. Low-level contamination in a population study may be tolerable, but it is disqualifying in clinical or assembly contexts.

**Safety note.** Laboratory decontamination typically involves fresh 10 percent bleach or equivalent disinfectant on work surfaces. Bleach corrodes stainless steel and releases fumes. Prepare it fresh daily, wear eye protection and gloves, and never mix bleach with other cleaning agents.

### 5. Duplicate reads from PCR and optics

**Mechanism.** Every library preparation amplifies fragments before sequencing. Two reads derived from the same original molecule are duplicates, and if you treat them as independent evidence you overcount support for variants and skew expression estimates. Optical duplicates arise when a single cluster is photographed multiple times and counted as separate reads.

**How to confirm.** After alignment, run Picard MarkDuplicates and read the metrics file. Compare library-level duplication rates across samples. Very high duplication in one sample with a low fragment diversity signature points to a library that started with too little input.

**Fix.** Mark or remove duplicates before variant calling and quantify their effect on downstream statistics. Duplicates are information, not just noise. In RNA-seq, high duplication in a high-expression transcriptome can be normal, so interpret the metric in context. A library with excessive duplication from low input should be rebuilt.

### 6. Sample mix-ups and swaps

**Mechanism.** Plate maps get transposed, tubes get swapped during extraction, barcodes get misread at the sequencer. A swapped pair can pass every per-sample QC check and still destroy a study, because every downstream association is computed against the wrong phenotype.

**How to confirm.** The most reliable check is genotype concordance. The Personal Genome Project-UK resource implemented explicit quality control and validation procedures to ensure data integrity and exclude sample mix-ups, using cross-omics genotype checks on its reference panel [3]. For SNP array data, compare the genotypes at a set of common SNPs against a reference or against a previously genotyped aliquot of the same sample. Check sex markers against recorded sex. For RNA-seq, verify that expressed variants match the sample's genotype.

**Fix.** Build a sample identity check into the pipeline as a hard gate, not an optional report. At the bench, use scanned barcodes at every handoff and record transfers electronically. The cost of a rerun is trivial compared with the cost of publishing a study built on swapped samples.

### 7. Batch effects confounded with biology

**Mechanism.** Samples processed in different batches, on different instruments, with different reagent lots, or by different operators acquire systematic differences in measured values. The danger is correlation between batch and condition. If all case samples ran on one flow cell and all controls on another, no computational correction can cleanly separate batch from biology.

**How to confirm.** Plot a [principal component analysis](/blog/data-analysis/principal-component-analysis-explained) of expression or abundance values colored by batch and by condition. QoRTs was designed to cross-compare RNA-seq replicates contrasted by batch, biological sample, or experimental condition, revealing outliers and systematic issues that could drive false associations [2]. At the feature level, the OBC pipeline uses principal variance component analysis to quantify how much variation is attributable to batch before and after correction [4].

**Fix.** The primary fix is experimental design. Randomize samples across batches so that batch is not confounded with condition, and include biological replicates within each batch. When design is balanced, normalization and batch correction methods can remove technical variation while preserving real biological differences. The OBC pipeline illustrates the two-tier logic. First-tier QC assesses the data structure, and second-tier QC compares differentially expressed molecules with known regulatory roles before and after correction to verify that biology survived the correction [4]. Never apply a correction to an unbalanced design and report the result as if the confound were removed.

### 8. Array-specific failures in genotyping data

**Mechanism.** SNP array calls depend on DNA quality, hybridization efficiency, and cluster position. Degraded DNA, insufficient input, or edge effects on the chip produce samples with low call rates, aberrant heterozygosity, or clusters that smear, all of which propagate spurious results into genome-wide association studies if left unfiltered.

**How to confirm.** Standard QC metrics include sample call rate, SNP call rate, heterozygosity outliers, sex discordance, relatedness, and Hardy-Weinberg deviations. The SNPQC pipeline applies a wide range of these metrics with user-defined thresholds and produces a filtered dataset plus a genomic relationship matrix ready for downstream analysis [5]. GTQC automates most of the same steps and produces an HTML report of quality metrics for rapid inspection before GWAS [6]. The practical workflow, from raw intensity data to a fully filtered dataset, is documented step by step in the standard QC chapter for SNP-based genotyping methods [7].

**Fix.** Filter low-quality samples first, then low-quality SNPs, then recheck. A sample that fails call rate QC is usually a DNA or handling problem. The fix is a second genotyping attempt with fresh DNA, not threshold shopping. SNPQC also maintains a database of genotypic, phenotypic, and quality metrics across runs, which matters in long-running programs where data integrity must persist as new samples arrive [5].

### 9. Metadata errors, format drift, and schema violations

**Mechanism.** Metadata (sample IDs, phenotypes, processing parameters, batch labels) is usually curated by hand and rarely validated. A single transposed ID or unit mismatch silently corrupts an analysis. On the structural side, data repositories accept files that comply with a formal schema or do not, and undetected schema violations break programmatic reuse. Reviews of data reuse in molecular oncology report exactly this pattern. Differences in experimental design, acquisition strategy, and metadata quality still limit reproducibility and cross-study comparability, even as public repositories grow [8].

**How to confirm.** Validate every file against its governing schema on ingest. The mmCIF Validator performs dictionary compliance and value checks for structural biology files, available both as an interactive editor extension and as a command-line script suitable for batch processing and CI or CD pipelines [9]. Apply the same idea to your own metadata with schema validation in the ingestion code.

**Fix.** Treat metadata as data. Give it a versioned schema, validate at ingest, and store it alongside the raw files. Map all local identifiers to a standard data model when integrating across sites. The All Of Us program demonstrates the approach at national scale, transforming site-specific i2b2 data into the OMOP common data model through ontology-driven mappings rather than site-specific programming [10].

### 10. Genome misassemblies

**Mechanism.** De novo assemblers rely on heuristics that fail in repetitive regions. Read errors and algorithmic shortcuts produce contigs that join unrelated loci, and every downstream annotation or variant call on a misassembled region inherits the error. Assemblers such as Flye and Shasta produce excellent drafts, but drafts are drafts.

**How to confirm.** Stash, a hash-based data structure built on stochastic tile hashing of k-mers from spaced seed windows, can query whether two genomic regions are covered by the same set of reads and thereby detect misassemblies. It detected misassemblies in human assemblies generated by Flye and Shasta from PacBio HiFi reads, and scaffolding Stash-cut assemblies reduced misassembly-linked errors in that evaluation [11]. Complementary signals include abnormally high read depth at contig joins and discontinuities in long-read alignment.

**Fix.** Detect, cut, and rescaffold. Then validate with independent evidence such as optical maps or linkage data where available. Never treat a raw assembly as finished.

### 11. Errors amplified by downstream AI models

**Mechanism.** Generative and foundation models trained on sequence data inherit every flaw in their training corpus, then interpolate new errors on top of them. A safety-focused analysis of foundation models in genomics notes that these models can exacerbate existing data quality issues and technical biases, particularly in clinical genetics and precision medicine applications [12]. Big data research more broadly shows the same dynamic. Large sample sizes do not guarantee more precise estimates, and ongoing attention to the quality and rigor of data collation and analysis remains necessary even as datasets grow [13].

**How to confirm.** Benchmark any model output against an independent, hand-curated truth set before deployment. Track whether model errors cluster in the same artifact classes described above, because they usually do.

**Fix.** Apply the same QC gates to AI-assisted steps as to any other pipeline step, document training data provenance, and keep a human in the loop for clinical or regulatory interpretations [12].

## Troubleshooting Table

| Symptom | Likely cause | How to confirm | Fix |
|--|--|--|--|
| Quality scores drop sharply in the last 20 to 30 bases of every read | Normal cycle decay or chemistry degradation | FastQC per-base quality plot, cycle-level profiling with Mapinsights [1] | Trim tails and proceed, or resequence if the whole read is poor |
| Adapter module near 100 percent early in reads | Inserts shorter than read length | cutadapt report-only run against expected adapter sequence | Trim before alignment, size-select inserts in the next library prep |
| Per-base quality is bimodal or sawtooth across the whole read | Sequencing chemistry or instrument fault | Mapinsights cluster analysis flags the run as an artifact outlier [1] | Contact the sequencing provider, request a rerun |
| One sample has coverage 10-fold different from its group | Loading concentration or quantification error | Per-sample depth statistics, Mapinsights depth anomaly detection [1] | Req quantify and resequence the sample |
| Unexpected heterozygosity or foreign-species reads | Index hopping, carryover, or cross-sample contamination | FastQ Screen or Kraken2, VerifyBamID contamination estimate, sex check | Unique dual indexes, physical separation of pre- and post-PCR areas, exclude affected samples |
| Duplication rate far above cohort peers | Low library input or overamplification | Picard MarkDuplicates metrics | Rebuild the library, remove duplicates in existing data before calling |
| Cases and controls separate perfectly on PCA before any biological signal is tested | Batch confounded with condition | QoRTs batch cross-comparisons [2], principal variance component analysis [4] | Redesign with randomization across batches. Correction cannot rescue a fully confounded design |
| PCA shifts after batch correction in a way that destroys known biology | Overcorrection | Second-tier QC comparing known regulatory molecules before and after correction [4] | Re-run with a less aggressive correction or a different method, keep the uncorrected data |
| Samples fail call rate or show heterozygosity extremes on arrays | Degraded DNA, low input, chip edge effects | SNPQC or GTQC reports with call rate, heterozygosity, and sex checks [5] [6] | Regenerate DNA, repeat genotyping, filter failed samples before SNP filtering |
| Reported sample sex does not match heterozygosity on X | Sample swap or metadata error | Genotype concordance against reference or matched aliquot [3] | Halt the pipeline, resolve identity at the source, correct the manifest |
| Pipeline breaks on files from a new site or year | Metadata format drift or schema violation | Schema validation at ingest, mmCIF-style dictionary checks [9] | Versioned schemas, validation gates, mapping to a common data model [10] |
| Contig joins read depth spikes and long-read alignments split | Genome misassembly | Stash misassembly detection, read-depth inspection [11] | Cut and rescaffold, validate with independent evidence |
| AI model output disagrees with curated truth on specific variant classes | Training data artifacts inherited and amplified | Benchmark against an independent truth set [12] | Gate model steps with the same QC as the rest of the pipeline |

## How to Fix Genomics Data Quality Issues: A Diagnostic Sequence

When a dataset looks wrong, work through this sequence in order. Each step either resolves the problem or tells you which section above to read in full.

1. **Inspect raw reads.** Run FastQC on every FASTQ file and summarize with MultiQC. Read the per-base quality, adapter content, overrepresented sequences, and per-sequence GC plots. This takes minutes and resolves the two most common classes of problems.
2. **Check run-level outliers.** Compare QC summaries across all samples in the batch. A tool built for cross-sample comparison, such as MultiQC for reads or QoRTs for RNA-seq [2], turns twelve individual reports into one decision-ready table. Any sample that sits apart from its peers gets a second look before analysis.
3. **Profile artifacts after alignment.** Run Mapinsights on the BAM files. Its cluster analysis on alignment-derived QC features detects cycle, chemistry, and library artifacts that read-level tools cannot see, and its depth analysis flags sequencing-depth anomalies [1].
4. **Verify sample identity.** Check sex markers, genotype concordance, and cross-omics consistency. Do this before computing a single association statistic.
5. **Quantify contamination and duplicates.** FastQ Screen for taxonomy, VerifyBamID for human contamination, Picard for duplicates. Decide per sample whether the level is tolerable for your analysis or the sample needs resequencing.
6. **Test for batch structure.** PCA colored by batch and by condition. If batch and condition are confounded, stop and redesign. If they are balanced, apply normalization and batch correction with a two-tier validation that confirms known biology survives the correction [4].
7. **Validate metadata.** Schema-check every manifest and mapping file at ingest, and reconcile sample counts, IDs, and units against the raw data.
8. **Apply filters once, document them, and freeze the dataset.** Record every threshold and every excluded sample in a versioned configuration file so the QC is reproducible. Automation of data storage, filtering, and manipulation is emphasized in standard GWAS QC practice precisely because manual steps erode integrity over time [7].

## Bioinformatics Data Management and Genomics Data Storage

Fixes at the analysis level only go so far if the underlying data management is weak. A systematic review of data stewardship in AI-based genomics consolidates the key domains you need to govern: data governance, quality management, privacy, ownership, access control, accountability, traceability, curation frameworks, and storage systems [14]. In practice this translates into a few concrete commitments.

**Store raw data immutably.** Raw FASTQ and BCL files are the ground truth. Keep them read-only, checksum them on write, and never regenerate them from derived files. A corrupted raw file discovered two years later is unrecoverable unless a checksum caught it on day one.

**Version everything derived.** Alignment files, variant calls, QC reports, and filtered datasets each need a version tied to the exact code and parameters that produced them. Workflow engines such as Nextflow or Snakemake exist for this reason. A dataset whose provenance is undocumented is a dataset you cannot trust or defend.

**Plan storage around volume.** Genomics data storage budgets grow fast. A single 30-fold human whole genome is roughly 100 GB as FASTQ and tens of GB as compressed BAM or CRAM, and a 1,000-sample project multiplies that a thousandfold. Tier your storage, keeping active data on fast storage and raw archives on cheaper object storage, but always with integrity verification at each tier. Stewardship reviews note that storage systems, access control, and traceability are inseparable parts of maintaining data integrity in large genomic programs [14].

**Standardize schemas and identifiers.** When data flows across sites or into combined analyses, format drift is the failure mode. The i2b2-to-OMOP transformation developed for the All Of Us program shows how ontology-driven mappings let multiple sites converge on one data model without bespoke programming at each site [10]. The same principle applies at lab scale. One canonical sample ID, used identically in the LIMS, the manifest, and the pipeline, prevents an entire class of mix-ups.

**Curate for reuse.** If your data will ever be shared, curate it for a stranger. Reviews of public data reuse find that differences in experimental design, workflow choices, and metadata quality are what limit cross-study comparability, not data availability [8]. Sharing also carries governance obligations. A systematic review of collaborative human genomic research in low- and middle-income countries documents the ethical, legal, and social considerations that shape how data sharing is structured, including consent scope and access control [15]. Build those considerations into the storage design rather than bolting them on later.

**Respect pre-analytical provenance.** Many quality problems originate before the sequencer ever runs. Biobanking standardization work emphasizes that how samples are collected, stored, and processed determines whether downstream measurements are valid, and that sample suitability must be documented and validated to establish the context for interpreting results [16]. Record collection conditions, processing time, and storage history as first-class metadata.

## Prevention Practices That Eliminate Most Recurring Issues

- **Run QC before you sequence.** Assess DNA or RNA integrity with a fragment analyzer before library prep. Sample integrity at the pre-analytical stage is the cheapest QC you will ever do [16].
- **Randomize across batches.** Distribute cases and controls across flow cells, extraction batches, and operators so batch is estimable and separable from condition [2].
- **Use unique dual indexes on patterned flow cells.** This is the direct countermeasure to index hopping.
- **Automate QC as pipeline gates.** Tools such as GTQC produce a full QC report automatically and cut manual QC labor dramatically [6]. Wire the report into the pipeline so a failing sample halts the run rather than surfacing in a paper review.
- **Validate identity at every handoff.** Barcode scans, genotype concordance checks, and cross-omics consistency checks like those used in the PGP-UK reference panel [3].
- **Validate files against schemas on ingest.** Whether it is mmCIF for structures [9] or your own metadata YAML, automated validation catches format drift the day it happens.
- **Keep raw data immutable and checksummed.** Traceability and integrity depend on it [14].
- **Document thresholds and versions.** Every filter threshold, every software version, every reference genome build, in a version-controlled config file. This is what makes a QC pass reproducible rather than anecdotal.

## Common Mistakes and Limitations

**Over-trimming reads.** Aggressive adapter and quality trimming discards real signal and can bias insertion-size distributions and GC profiles. Trim only what the diagnostics show is broken, then confirm with a second QC pass.

**Treating QC thresholds as universal.** A call rate threshold or duplication cutoff that suits one assay can be wrong for another. Thresholds should be justified by your assay and your cohort, informed by the standard metrics, not copied blindly [5] [7].

**Correcting batch effects on a confounded design.** Batch correction methods adjust technical variation. When batch and condition are fully confounded, the correction removes biology along with the batch signal or fails silently. A second-tier check that compares known regulatory molecules before and after correction is the safeguard the OBC pipeline formalizes [4].

**Trusting sample size over data quality.** Big datasets enable well-powered analyses, but sample size alone does not guarantee more precise estimates, and rigor in collation and analysis remains the [limiting factor](/blog/guides/limiting-factor-definition-types-and-examples) [13].

**Reusing public data without auditing it.** Repositories make data available, not necessarily comparable. Check experimental design, quantification workflow, and metadata before integrating a downloaded dataset into your own analysis [8].

**Assuming AI outputs are cleaner than inputs.** Foundation models inherit and can amplify the flaws of their training data. Treat model outputs with the same skepticism as any other derived data.

**Skipping identity checks because per-sample QC looks fine.** A swapped sample passes its own QC perfectly. Only cross-checks against genotype, sex, or matched aliquots catch swaps.

**Normalizing across assay types with borrowed methods.** Normalization algorithms are not automatically transferable between omics domains because workflows and data characteristics differ. Match the normalization type, sample normalization, signal correction, or statistical scaling, to the specific problem you are solving [17].

Individual datasets and clinical interpretations always need review by a specialist who knows the assay, the cohort, and the biological question. Use this article as a diagnostic map, not as a substitute for that judgment.

## Frequently Asked Questions

### What causes most genomics data quality issues?

Technical artifacts from the sequencing instrument and library preparation, followed by batch effects and sample handling errors. Cycle-level signal decay, adapter read-through, uneven coverage, and sample swaps account for the majority of problems encountered in practice [1].

### How do I fix low per-base quality scores at the ends of reads?

Trim the low-quality tails with cutadapt or Trimmomatic and re-run FastQC to confirm. If quality is poor across the entire read rather than just the tail, the run itself is suspect and the fix is a rerun, not heavier trimming.

### How can I tell if my data has batch effects?

Plot a PCA of your normalized values colored by batch and by condition. Clustering by batch, especially when batch aligns with condition, indicates a batch effect. QoRTs provides batch-contrasted replicate comparisons for RNA-seq specifically [2].

### What is index hopping and how do I prevent it?

Index hopping is the misassignment of sample barcode sequences during sequencing on patterned flow cells, which attaches reads to the wrong sample. Prevent it with unique dual indexes and careful multiplex design. Confirm contamination in existing data with genotype-based tools and taxonomy screens.

### How do I detect a sample mix-up in my sequencing data?

Compare the variants observed in the sequencing data against a reference genotype for that sample, check sex markers against recorded sex, and verify cross-omics consistency. The PGP-UK reference panel used exactly these validation procedures to exclude mix-ups [3].

### How much storage do I need for a whole human genome?

A 30-fold whole [human genome](/blog/guides/human-genome) is roughly 100 GB as raw FASTQ and substantially less as compressed BAM or CRAM, so plan for on the order of a few hundred GB per sample once QC files, indexes, and intermediates are counted. Tier storage by access frequency and verify integrity with checksums at every tier [14].

### Can I trust public data I download for reanalysis?

Verify it the same way you would verify your own data. Check metadata completeness, experimental design consistency, and cross-sample QC before integration. Metadata quality and workflow heterogeneity are the main limits on cross-study comparability in public repositories [8].

### Do I need to trim adapters and low-quality bases before alignment?

Yes when the diagnostics show adapter content or a low-quality tail, because both inflate mismatch rates and degrade mapping. Trim exactly what the QC plots show, avoid over-trimming, and confirm the result with a second QC pass.

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "What causes most genomics data quality issues?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Technical artifacts from the sequencing instrument and library preparation, followed by batch effects and sample handling errors. Cycle-level signal decay, adapter read-through, uneven coverage, and sample swaps account for the majority of problems encountered in practice."
      }
    },
    {
      "@type": "Question",
      "name": "How do I fix low per-base quality scores at the ends of reads?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Trim the low-quality tails with cutadapt or Trimmomatic and re-run FastQC to confirm. If quality is poor across the entire read rather than just the tail, the run itself is suspect and the fix is a rerun, not heavier trimming."
      }
    },
    {
      "@type": "Question",
      "name": "How can I tell if my data has batch effects?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Plot a PCA of your normalized values colored by batch and by condition. Clustering by batch, especially when batch aligns with condition, indicates a batch effect. QoRTs provides batch-contrasted replicate comparisons for RNA-seq specifically."
      }
    },
    {
      "@type": "Question",
      "name": "What is index hopping and how do I prevent it?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Index hopping is the misassignment of sample barcode sequences during sequencing on patterned flow cells, which attaches reads to the wrong sample. Prevent it with unique dual indexes and careful multiplex design. Confirm contamination in existing data with genotype-based tools and taxonomy screens."
      }
    },
    {
      "@type": "Question",
      "name": "How do I detect a sample mix-up in my sequencing data?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Compare the variants observed in the sequencing data against a reference genotype for that sample, check sex markers against recorded sex, and verify cross-omics consistency. The PGP-UK reference panel used exactly these validation procedures to exclude mix-ups."
      }
    },
    {
      "@type": "Question",
      "name": "How much storage do I need for a whole human genome?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "A 30-fold whole human genome is roughly 100 GB as raw FASTQ and substantially less as compressed BAM or CRAM, so plan for on the order of a few hundred GB per sample once QC files, indexes, and intermediates are counted. Tier storage by access frequency and verify integrity with checksums at every tier."
      }
    },
    {
      "@type": "Question",
      "name": "Can I trust public data I download for reanalysis?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Verify it the same way you would verify your own data. Check metadata completeness, experimental design consistency, and cross-sample QC before integration. Metadata quality and workflow heterogeneity are the main limits on cross-study comparability in public repositories."
      }
    },
    {
      "@type": "Question",
      "name": "Do I need to trim adapters and low-quality bases before alignment?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes when the diagnostics show adapter content or a low-quality tail, because both inflate mismatch rates and degrade mapping. Trim exactly what the QC plots show, avoid over-trimming, and confirm the result with a second QC pass."
      }
    }
  ]
}
</script>

## Sources

1. [Mapinsights: deep exploration of quality issues and error profiles in high-throughput sequence data.](https://pubmed.ncbi.nlm.nih.gov/37378434/)
2. [QoRTs: a comprehensive toolset for quality control and data processing of RNA-Seq experiments.](https://pubmed.ncbi.nlm.nih.gov/26187896/)
3. [The Personal Genome Project-UK, an open access resource of human multi-omics data.](https://pubmed.ncbi.nlm.nih.gov/31672996/)
4. [OBC: Optimized Batch Correction with Dual-level Quality Control for Scalable Proteomics and Metabolomics.](https://pubmed.ncbi.nlm.nih.gov/42033786/)
5. [SNPQC--an R pipeline for quality control of Illumina SNP genotyping array data.](https://pubmed.ncbi.nlm.nih.gov/25040453/)
6. [GTQC: Automated Genotyping Array Quality Control and Report.](https://pubmed.ncbi.nlm.nih.gov/35300047/)
7. [Quality control for genome-wide association studies.](https://pubmed.ncbi.nlm.nih.gov/23756889/)
8. [Beyond Reanalysis: Critical Issues in Data Reuse for Solid Tumor Proteomics.](https://pubmed.ncbi.nlm.nih.gov/42029488/)
9. [mmCIF Validator: a comprehensive validation tool for structural biology data files.](https://pubmed.ncbi.nlm.nih.gov/42559167/)
10. [Data model harmonization for the All Of Us Research Program: Transforming i2b2 data into the OMOP common data model.](https://pubmed.ncbi.nlm.nih.gov/30779778/)
11. [Genome misassembly detection using Stash: A data structure based on stochastic tile hashing.](https://pubmed.ncbi.nlm.nih.gov/42441722/)
12. [A safety-centric perspective on innovation and risk in the use of artificial intelligence in genomics.](https://pubmed.ncbi.nlm.nih.gov/42062163/)
13. [Big data and psychiatry: advances, constraints and future directions.](https://pubmed.ncbi.nlm.nih.gov/42742616/)
14. [Data stewardship and curation practices in AI-based genomics and automated microscopy image analysis for high-throughput screening studies: promoting robust and ethical AI applications.](https://pubmed.ncbi.nlm.nih.gov/39988670/)
15. [Context of data sharing practices in collaborative human genomic research in low and middle income countries: A systematic review.](https://pubmed.ncbi.nlm.nih.gov/42566494/)
16. [Developments in biobanking workflow standardization providing sample integrity and stability.](https://pubmed.ncbi.nlm.nih.gov/23856607/)
17. [The Multifaceted Challenge of Normalizing Mass Spectrometry-Based Metabolomics Data.](https://pubmed.ncbi.nlm.nih.gov/42081666/)